Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Maternal Exposure | 18 | 2023 | 961 | 2.190 |
Why?
|
Environmental Pollutants | 24 | 2023 | 1180 | 2.180 |
Why?
|
Phthalic Acids | 18 | 2023 | 436 | 2.170 |
Why?
|
Pre-Eclampsia | 17 | 2023 | 1200 | 2.120 |
Why?
|
Premature Birth | 20 | 2023 | 1721 | 1.910 |
Why?
|
Phenols | 16 | 2023 | 501 | 1.850 |
Why?
|
Pregnancy | 97 | 2024 | 29142 | 1.250 |
Why?
|
Lead | 10 | 2021 | 854 | 1.130 |
Why?
|
Benzhydryl Compounds | 8 | 2018 | 845 | 0.960 |
Why?
|
Fetal Development | 9 | 2023 | 767 | 0.890 |
Why?
|
Environmental Exposure | 13 | 2023 | 4236 | 0.860 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 8 | 2023 | 552 | 0.860 |
Why?
|
Fetal Growth Retardation | 9 | 2023 | 570 | 0.850 |
Why?
|
Gestational Age | 21 | 2023 | 3493 | 0.800 |
Why?
|
Cell-Derived Microparticles | 3 | 2020 | 168 | 0.790 |
Why?
|
Fluorocarbons | 2 | 2023 | 452 | 0.720 |
Why?
|
Birth Weight | 13 | 2023 | 2069 | 0.710 |
Why?
|
Oxidative Stress | 10 | 2024 | 3085 | 0.690 |
Why?
|
Pregnancy Trimester, First | 8 | 2022 | 853 | 0.600 |
Why?
|
Endocrine Disruptors | 4 | 2021 | 237 | 0.510 |
Why?
|
Dinoprost | 4 | 2019 | 138 | 0.500 |
Why?
|
Metals | 4 | 2019 | 719 | 0.500 |
Why?
|
Infant, Small for Gestational Age | 5 | 2022 | 440 | 0.480 |
Why?
|
Mexico | 13 | 2019 | 690 | 0.480 |
Why?
|
Pregnancy Proteins | 4 | 2015 | 229 | 0.470 |
Why?
|
Case-Control Studies | 28 | 2023 | 21752 | 0.470 |
Why?
|
Placenta Previa | 3 | 2023 | 117 | 0.460 |
Why?
|
Pregnancy Complications | 7 | 2022 | 2862 | 0.460 |
Why?
|
Oxylipins | 2 | 2024 | 49 | 0.430 |
Why?
|
Ultrasonography, Prenatal | 10 | 2022 | 1695 | 0.430 |
Why?
|
Pregnancy Trimester, Third | 8 | 2023 | 571 | 0.430 |
Why?
|
Water Pollutants, Chemical | 2 | 2013 | 311 | 0.410 |
Why?
|
Estrogens | 1 | 2019 | 1565 | 0.400 |
Why?
|
Pregnancy Trimesters | 4 | 2019 | 192 | 0.400 |
Why?
|
Pregnant Women | 7 | 2023 | 568 | 0.380 |
Why?
|
Fetal Macrosomia | 3 | 2022 | 124 | 0.350 |
Why?
|
Female | 102 | 2024 | 380197 | 0.350 |
Why?
|
Transferrin | 1 | 2010 | 295 | 0.340 |
Why?
|
Infant, Newborn | 28 | 2023 | 25618 | 0.340 |
Why?
|
Deoxyguanosine | 3 | 2018 | 84 | 0.340 |
Why?
|
Parabens | 4 | 2018 | 108 | 0.330 |
Why?
|
Substance Abuse Detection | 2 | 2021 | 283 | 0.320 |
Why?
|
Eicosanoids | 2 | 2020 | 279 | 0.320 |
Why?
|
Placenta Accreta | 3 | 2023 | 225 | 0.310 |
Why?
|
Placenta | 6 | 2023 | 1697 | 0.310 |
Why?
|
Inflammation | 8 | 2024 | 10634 | 0.290 |
Why?
|
Environmental Monitoring | 7 | 2018 | 1414 | 0.290 |
Why?
|
Obstetric Labor Complications | 2 | 2019 | 238 | 0.280 |
Why?
|
Thyroid Hormones | 3 | 2018 | 390 | 0.270 |
Why?
|
Flame Retardants | 2 | 2023 | 87 | 0.260 |
Why?
|
Adult | 56 | 2022 | 214035 | 0.260 |
Why?
|
Puerto Rico | 6 | 2015 | 356 | 0.250 |
Why?
|
Umbilical Cord | 2 | 2018 | 180 | 0.240 |
Why?
|
F2-Isoprostanes | 1 | 2024 | 35 | 0.240 |
Why?
|
Pregnancy Trimester, Second | 4 | 2021 | 732 | 0.240 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2010 | 1366 | 0.240 |
Why?
|
Humans | 103 | 2024 | 744220 | 0.230 |
Why?
|
Models, Theoretical | 1 | 2016 | 3591 | 0.230 |
Why?
|
Alanine Transaminase | 2 | 2016 | 592 | 0.230 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2023 | 65 | 0.230 |
Why?
|
Insecticides | 2 | 2015 | 195 | 0.220 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2023 | 140 | 0.210 |
Why?
|
Phenol | 2 | 2023 | 43 | 0.210 |
Why?
|
Isoprostanes | 2 | 2024 | 21 | 0.210 |
Why?
|
Maternal Age | 4 | 2021 | 802 | 0.210 |
Why?
|
Iron | 1 | 2010 | 1774 | 0.200 |
Why?
|
Gonadal Steroid Hormones | 2 | 2017 | 711 | 0.200 |
Why?
|
Blood Group Antigens | 1 | 2023 | 180 | 0.200 |
Why?
|
Cohort Studies | 18 | 2021 | 40559 | 0.200 |
Why?
|
Neovascularization, Physiologic | 3 | 2019 | 1351 | 0.200 |
Why?
|
Alkanesulfonic Acids | 1 | 2023 | 180 | 0.190 |
Why?
|
Diabetes, Gestational | 3 | 2022 | 1184 | 0.190 |
Why?
|
Consumer Product Safety | 1 | 2021 | 122 | 0.190 |
Why?
|
Trace Elements | 2 | 2019 | 198 | 0.180 |
Why?
|
Eclampsia | 1 | 2020 | 58 | 0.180 |
Why?
|
Fever | 2 | 2019 | 1614 | 0.180 |
Why?
|
Cosmetics | 1 | 2021 | 97 | 0.180 |
Why?
|
Pregnancy Outcome | 7 | 2023 | 2796 | 0.180 |
Why?
|
Neonatal Abstinence Syndrome | 1 | 2021 | 109 | 0.180 |
Why?
|
Placentation | 1 | 2019 | 82 | 0.170 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2019 | 2408 | 0.170 |
Why?
|
Linear Models | 5 | 2022 | 5953 | 0.170 |
Why?
|
Estrone | 1 | 2020 | 240 | 0.170 |
Why?
|
Boston | 10 | 2021 | 9311 | 0.170 |
Why?
|
Young Adult | 24 | 2020 | 56436 | 0.160 |
Why?
|
Lead Poisoning | 2 | 2012 | 304 | 0.160 |
Why?
|
Amine Oxidase (Copper-Containing) | 1 | 2018 | 41 | 0.160 |
Why?
|
Carbanilides | 1 | 2018 | 17 | 0.160 |
Why?
|
Prospective Studies | 16 | 2023 | 53280 | 0.160 |
Why?
|
Benzophenones | 1 | 2018 | 57 | 0.160 |
Why?
|
Analgesia, Obstetrical | 1 | 2019 | 177 | 0.160 |
Why?
|
Prolactin | 1 | 2020 | 669 | 0.150 |
Why?
|
Labor Stage, Second | 1 | 2017 | 31 | 0.150 |
Why?
|
Labor Presentation | 1 | 2017 | 53 | 0.150 |
Why?
|
Glucose Intolerance | 1 | 2022 | 577 | 0.150 |
Why?
|
Logistic Models | 8 | 2019 | 13409 | 0.140 |
Why?
|
Infant, Newborn, Diseases | 1 | 2022 | 582 | 0.140 |
Why?
|
Vitamin D | 3 | 2021 | 3222 | 0.140 |
Why?
|
Trophoblasts | 1 | 2018 | 215 | 0.140 |
Why?
|
Cities | 2 | 2019 | 513 | 0.140 |
Why?
|
Cervical Length Measurement | 1 | 2016 | 41 | 0.140 |
Why?
|
Food Contamination | 2 | 2014 | 189 | 0.140 |
Why?
|
Analgesia, Epidural | 1 | 2019 | 326 | 0.140 |
Why?
|
Perineum | 1 | 2017 | 211 | 0.140 |
Why?
|
Body Mass Index | 5 | 2019 | 12718 | 0.140 |
Why?
|
Chromatography, Liquid | 2 | 2019 | 977 | 0.140 |
Why?
|
Cytokines | 4 | 2019 | 7326 | 0.130 |
Why?
|
Mass Spectrometry | 3 | 2020 | 2204 | 0.130 |
Why?
|
Delivery, Obstetric | 3 | 2017 | 906 | 0.130 |
Why?
|
Fatty Acids | 1 | 2023 | 1808 | 0.130 |
Why?
|
Progesterone | 1 | 2020 | 776 | 0.130 |
Why?
|
Sexual Maturation | 1 | 2017 | 265 | 0.130 |
Why?
|
Insect Repellents | 1 | 2014 | 17 | 0.130 |
Why?
|
Matrix Metalloproteinases | 1 | 2017 | 391 | 0.130 |
Why?
|
Patient Selection | 2 | 2017 | 4216 | 0.130 |
Why?
|
Self-Assessment | 1 | 2017 | 390 | 0.130 |
Why?
|
Thyroid Diseases | 1 | 2018 | 378 | 0.120 |
Why?
|
Respiratory Rate | 1 | 2015 | 162 | 0.120 |
Why?
|
Herbicides | 1 | 2014 | 100 | 0.120 |
Why?
|
Interleukin-1beta | 1 | 2019 | 972 | 0.120 |
Why?
|
Vitamin D Deficiency | 2 | 2021 | 1343 | 0.120 |
Why?
|
Organophosphorus Compounds | 1 | 2015 | 215 | 0.120 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2015 | 2026 | 0.120 |
Why?
|
ROC Curve | 3 | 2016 | 3527 | 0.120 |
Why?
|
Prenatal Care | 2 | 2023 | 1092 | 0.110 |
Why?
|
Metabolome | 1 | 2020 | 895 | 0.110 |
Why?
|
Membrane Proteins | 1 | 2010 | 7879 | 0.110 |
Why?
|
Massachusetts | 4 | 2023 | 8663 | 0.110 |
Why?
|
Weight Gain | 2 | 2023 | 2292 | 0.110 |
Why?
|
Risk Factors | 16 | 2019 | 72280 | 0.110 |
Why?
|
Cervix Uteri | 1 | 2016 | 590 | 0.110 |
Why?
|
Estradiol | 1 | 2020 | 2020 | 0.110 |
Why?
|
Environmental Illness | 1 | 2012 | 34 | 0.100 |
Why?
|
Mercury | 1 | 2014 | 285 | 0.100 |
Why?
|
Head | 1 | 2017 | 880 | 0.100 |
Why?
|
Stillbirth | 1 | 2014 | 346 | 0.100 |
Why?
|
RNA | 1 | 2022 | 2749 | 0.100 |
Why?
|
Esters | 2 | 2023 | 210 | 0.100 |
Why?
|
Seafood | 1 | 2014 | 384 | 0.100 |
Why?
|
Thyroid Gland | 1 | 2018 | 1172 | 0.100 |
Why?
|
Child Development | 2 | 2013 | 2223 | 0.100 |
Why?
|
Interleukin-10 | 1 | 2016 | 1200 | 0.090 |
Why?
|
Obesity | 5 | 2024 | 12742 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1889 | 0.090 |
Why?
|
Plasticizers | 2 | 2023 | 47 | 0.090 |
Why?
|
Body Burden | 1 | 2010 | 158 | 0.090 |
Why?
|
Mongolia | 2 | 2020 | 91 | 0.090 |
Why?
|
Nervous System | 1 | 2013 | 554 | 0.090 |
Why?
|
Air Pollution | 1 | 2023 | 2286 | 0.090 |
Why?
|
Infertility | 1 | 2016 | 655 | 0.090 |
Why?
|
Polymorphism, Genetic | 2 | 2010 | 4328 | 0.090 |
Why?
|
Adiposity | 1 | 2019 | 1807 | 0.090 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 788 | 0.090 |
Why?
|
Bayes Theorem | 3 | 2023 | 2309 | 0.080 |
Why?
|
Fetal Weight | 2 | 2022 | 80 | 0.080 |
Why?
|
Depression | 2 | 2019 | 7767 | 0.080 |
Why?
|
Hemochromatosis | 1 | 2010 | 184 | 0.080 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2010 | 284 | 0.080 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 25043 | 0.080 |
Why?
|
Bacteremia | 1 | 2015 | 962 | 0.080 |
Why?
|
Longitudinal Studies | 7 | 2020 | 13990 | 0.080 |
Why?
|
Fetus | 3 | 2023 | 1880 | 0.080 |
Why?
|
Odds Ratio | 5 | 2022 | 9849 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2016 | 3778 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14726 | 0.080 |
Why?
|
Maternal-Fetal Exchange | 2 | 2021 | 455 | 0.080 |
Why?
|
Bromine | 1 | 2007 | 23 | 0.080 |
Why?
|
Time Factors | 4 | 2019 | 40063 | 0.080 |
Why?
|
Parity | 3 | 2016 | 929 | 0.070 |
Why?
|
Fertilization in Vitro | 1 | 2015 | 1284 | 0.070 |
Why?
|
Fetal Blood | 2 | 2014 | 1317 | 0.070 |
Why?
|
Proteomics | 2 | 2020 | 3637 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2016 | 3201 | 0.070 |
Why?
|
Regression Analysis | 4 | 2019 | 6461 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12355 | 0.070 |
Why?
|
Male | 22 | 2023 | 350027 | 0.070 |
Why?
|
Sulfones | 2 | 2018 | 437 | 0.070 |
Why?
|
Infant, Premature | 1 | 2015 | 2044 | 0.070 |
Why?
|
Body Height | 1 | 2012 | 1576 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4044 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2867 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2021 | 4259 | 0.060 |
Why?
|
Adolescent | 13 | 2019 | 85759 | 0.060 |
Why?
|
Genotype | 3 | 2023 | 12956 | 0.060 |
Why?
|
Body Weight | 2 | 2014 | 4666 | 0.060 |
Why?
|
Heart Rate | 1 | 2015 | 4092 | 0.060 |
Why?
|
Thyroxine | 2 | 2018 | 666 | 0.060 |
Why?
|
Fishes | 1 | 2007 | 569 | 0.060 |
Why?
|
Antigens, CD | 1 | 2014 | 4026 | 0.060 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2023 | 26 | 0.060 |
Why?
|
Bone and Bones | 2 | 2011 | 2575 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2023 | 77426 | 0.060 |
Why?
|
Area Under Curve | 2 | 2019 | 1655 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6259 | 0.060 |
Why?
|
Glucose Tolerance Test | 2 | 2016 | 1150 | 0.050 |
Why?
|
Arachidonic Acid | 1 | 2024 | 434 | 0.050 |
Why?
|
Organ Size | 2 | 2018 | 2252 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2022 | 15070 | 0.050 |
Why?
|
Limit of Detection | 1 | 2022 | 265 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2010 | 1456 | 0.050 |
Why?
|
Pilot Projects | 2 | 2015 | 8321 | 0.050 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2024 | 546 | 0.050 |
Why?
|
Magnesium Sulfate | 1 | 2020 | 68 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 3658 | 0.050 |
Why?
|
Phosphates | 1 | 2023 | 786 | 0.040 |
Why?
|
Alpha-Globulins | 1 | 2019 | 29 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19907 | 0.040 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2019 | 49 | 0.040 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2019 | 31 | 0.040 |
Why?
|
Factor XIII | 1 | 2019 | 59 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 8986 | 0.040 |
Why?
|
Naphthalenesulfonates | 1 | 2017 | 15 | 0.040 |
Why?
|
Decidua | 1 | 2018 | 86 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2014 | 2970 | 0.040 |
Why?
|
Triclosan | 1 | 2018 | 55 | 0.040 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2017 | 141 | 0.040 |
Why?
|
Patella | 1 | 2019 | 320 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 284 | 0.040 |
Why?
|
Magnesium | 1 | 2020 | 813 | 0.040 |
Why?
|
Nutrition Surveys | 2 | 2014 | 1660 | 0.040 |
Why?
|
Probability | 1 | 2022 | 2505 | 0.040 |
Why?
|
Infant | 4 | 2024 | 35129 | 0.040 |
Why?
|
Diethylhexyl Phthalate | 1 | 2016 | 81 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2023 | 1236 | 0.030 |
Why?
|
Telomere | 1 | 2022 | 910 | 0.030 |
Why?
|
Triiodothyronine | 1 | 2018 | 494 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1223 | 0.030 |
Why?
|
Blood Pressure | 1 | 2011 | 8551 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2010 | 4041 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2019 | 1005 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7784 | 0.030 |
Why?
|
DEET | 1 | 2014 | 10 | 0.030 |
Why?
|
2,4,5-Trichlorophenoxyacetic Acid | 1 | 2014 | 12 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 576 | 0.030 |
Why?
|
2,4-Dichlorophenoxyacetic Acid | 1 | 2014 | 21 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 552 | 0.030 |
Why?
|
Tuna | 1 | 2014 | 19 | 0.030 |
Why?
|
DNA Methylation | 1 | 2009 | 4289 | 0.030 |
Why?
|
Child | 6 | 2022 | 77679 | 0.030 |
Why?
|
Genetic Variation | 1 | 2010 | 6546 | 0.030 |
Why?
|
Pyrethrins | 1 | 2014 | 47 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2021 | 780 | 0.030 |
Why?
|
Vitamins | 1 | 2023 | 1621 | 0.030 |
Why?
|
Parturition | 1 | 2018 | 441 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2015 | 402 | 0.030 |
Why?
|
Refractometry | 1 | 2014 | 56 | 0.030 |
Why?
|
Nuclear Family | 1 | 2015 | 318 | 0.030 |
Why?
|
Peripartum Period | 1 | 2015 | 133 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12244 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23337 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 638 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 1080 | 0.030 |
Why?
|
Sex Factors | 3 | 2013 | 10396 | 0.030 |
Why?
|
Models, Statistical | 2 | 2019 | 5102 | 0.030 |
Why?
|
Puberty | 1 | 2017 | 490 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2018 | 353 | 0.030 |
Why?
|
Hormones | 1 | 2018 | 887 | 0.030 |
Why?
|
Uterus | 1 | 2018 | 710 | 0.030 |
Why?
|
Veins | 1 | 2018 | 769 | 0.030 |
Why?
|
Adolescent Development | 1 | 2017 | 278 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1494 | 0.030 |
Why?
|
Tibia | 1 | 2019 | 1077 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39045 | 0.030 |
Why?
|
Arteries | 1 | 2018 | 1119 | 0.030 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2017 | 501 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1345 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20817 | 0.030 |
Why?
|
Mothers | 2 | 2015 | 2165 | 0.030 |
Why?
|
Hypertension | 1 | 2011 | 8480 | 0.020 |
Why?
|
Hair | 1 | 2014 | 483 | 0.020 |
Why?
|
Pyrroles | 1 | 2017 | 1143 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4982 | 0.020 |
Why?
|
Reference Standards | 1 | 2014 | 1025 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2020 | 1917 | 0.020 |
Why?
|
Parents | 1 | 2023 | 3407 | 0.020 |
Why?
|
Middle Aged | 4 | 2017 | 213367 | 0.020 |
Why?
|
Child, Preschool | 4 | 2013 | 40992 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6196 | 0.020 |
Why?
|
Cesarean Section | 1 | 2017 | 1365 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3305 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2886 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2018 | 2715 | 0.020 |
Why?
|
Demography | 1 | 2013 | 1656 | 0.020 |
Why?
|
Fresh Water | 1 | 2007 | 83 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 20945 | 0.020 |
Why?
|
Ethers | 1 | 2007 | 75 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1955 | 0.020 |
Why?
|
United States | 3 | 2020 | 69867 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2013 | 1901 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2010 | 2422 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2892 | 0.020 |
Why?
|
Postpartum Period | 1 | 2010 | 1086 | 0.010 |
Why?
|
Haplotypes | 1 | 2010 | 2781 | 0.010 |
Why?
|
Neutrophils | 1 | 2015 | 3717 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.010 |
Why?
|
Breast Feeding | 1 | 2011 | 1339 | 0.010 |
Why?
|
Energy Intake | 1 | 2010 | 2148 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2016 | 3863 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2016 | 3336 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7472 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 6991 | 0.010 |
Why?
|
Animals | 3 | 2022 | 168788 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6172 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12801 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2010 | 3297 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81178 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29050 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 11732 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15525 | 0.010 |
Why?
|